Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis.
Lytic and blastic lesions have been associated to malignant tumours, such as solid cancer (breast cancer, renal cancer, prostate cancer, malignant melanoma or thyroid tumours). Although a mixed pattern with lytic and blastic lesions is due to metastatic tumour, this is not the only possible origin. The following case shows a systematic. This case report shows the number of tests that were made in order to discover the origin of osteolytic and osteoblastic lesions and it is notable that there is not an occult neoplasia on every occasion.
Molina-Garrido
M José
MJ
Department of Oncology, General University Hospital in Elche, Elche, Alicante, Spain. mjmolinagarrido@hotmail.com
Mora
A
A
Andrada
Encarna
E
Guillén-Ponce
Carmen
C
Cánovas
Víctor
V
Guirado-Risueño
M
M
Pastor
Elisa
E
Molina
M Angeles
MA
Molina
M Jesús
MJ
Martín Hidalgo
Alberto
A
Carrato
Alfredo
A
D000368:Aged; D000740:Anemia / Q000150:complications; D001416:Back Pain / Q000209:etiology; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary*; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D007093:Imidazoles / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D034721:Mastocytosis, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D010014:Osteolysis / Q000188:drug therapy / Q000209:etiology*; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy; D011877:Radionuclide Imaging; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D007155:Immunologic Factors; D016898:Interferon-alpha; D000077211:Zoledronic Acid